Microline Surgical, Inc., a subsidiary of HOYA Corporation, has finalized the acquisition of specific laparoscopic instrumentation assets from RETRACTION Limited.
The acquisition encompasses the rights to the REVEEL branded products, a set of surgical instruments utilized by surgeons for liver retraction during laparoscopic surgeries. These REVEEL devices are meticulously designed to delicately retract the liver, ensuring an unobstructed view of the surgical site throughout procedures. Notably, the patented surface of REVEEL products serves to safeguard the liver, preventing any inadvertent sliding during surgical processes. These products have obtained clearance for sale across various countries, including the United States, the United Kingdom, and the European Union.
Timothy Gehlmann, President and Chief Executive Officer of Microline, expressed satisfaction with the agreement, underlining how the integration of REVEEL into Microline’s portfolio aligns with the company’s overarching goal. Gehlmann emphasized the significance of empowering customers to curtail surgical costs and complications while simultaneously enhancing surgical outcomes.
Stuart Moran, Chief Executive Officer of RETRACTION Limited, conveyed enthusiasm regarding the transition of rights for the REVEEL Endoscopic Retractor to Microline. Moran expressed confidence in Microline’s capabilities as a robust partner, envisioning a broader reach for their patented technology, consequently benefiting a larger populace of patients and medical professionals.
The acquisition signals Microline Surgical’s strategic move to augment its product offerings and reinforce its commitment to advancing surgical practices for improved patient care and operational efficiency.
